Bruce Cohen, M.D.

Bruce Howard Cohen, MD, earned his undergraduate degree in 1978 from Washington University in St. Louis. He graduated summa cum laude with a degree in chemistry. He received his medical degree in 1982 from the Albert Einstein College of Medicine in Bronx, N.Y. Following his pediatrics residency at the Children’s Hospital of Philadelphia, he served as a resident-fellow at Columbia Presbyterian Medical Center in N.Y., where he specialized in pediatric neurology. He then went to the Children's Hospital of Philadelphia as an American Cancer Society Fellow to serve a two-year fellowship in neuro-oncology.  Dr. Cohen joined Cleveland Clinic’s Department of Neurology in 1989. In 1999 he became Chief of the Section of Pediatric Neurology, with joint appointments in the Clinic’s Taussig Cancer Center, the Department of Neurosurgery and the Department of Pediatrics.
 
His specialty interests include adult and pediatric neuro-oncology, mitochondrial medicine, neurofibromatosis, neurometabolic diseases and pediatric neurology. He has served on a variety of committees for the Children’s Cancer Group, the American Academy of Neurology,  the Child Neurology Society, and also as Chair of the Infant Brain Tumor treatment study. He is an examiner for the American Board of Psychiatry and Neurology, and a fellow of the National Board of Medical Examiners, the American Board of Pediatrics, and the American Board of Psychiatry and Neurology, with Special Qualifications in Child Neurology.

A frequent invited lecturer, Dr. Cohen has made numerous television and radio appearances, and has received awards from the American Society of Clinical Oncology, the American Cancer Society, the Peter Preuss Foundation, and other medical research organizations. He is a member of the Child Neurology Society, the American Academy of Neurology, the American Epilepsy Society, the Sigma Xi North American Scientific Society and the Alpha Omega Alpha fraternal organization. He is also an ad hoc reviewer for Annals of Neurology, Neurology, Medical and Pediatric Oncology, the Journal of Neuro-Oncology and Muscle and Nerve.
 
Dr. Cohen has been named to both Best Doctors in Ohio and Best Doctors in America since 1994. He also served on the board of trustees of the United Mitochondrial Disease Foundation from 1999 to 2006 and is now a member of their Scientific and Medical Advisory Board.

Adult and pediatric neuro-oncology, mitochondrial medicine, Neurofibromatosis, neuro-metabolic diseases, Pediatric Neurology, adult and pediatric brain and spine tumors, adult and pediatric brain tumors, adult neuro-oncology, benign and malignant tumors of the brain and spinal cord, benign brain tumors (meningiomas, schwannomas), Brain Metastases, brain tumors, CNS metastatic disease, Meningiomas, molecular biology of brain tumors clinical and translational trials, pediatric neurology, tumors of the brain and spine.

• Best Doctors in America, 1994-Present
• Scientific and Medical Advisory Board, United Mitochondrial Disease Foundation

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Cohen has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Cohen receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:

• Sanofi-Aventis US Inc.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)